Alan K. Davis
Psychology · The Ohio State University
Publications
174
Citations
7,013
Est. group size
~11
Recurring co-author estimate
Active years
37
Publishing since 1990
Alan K. Davis studies the effects of psychedelic substances (such as psilocybin, ayahuasca, LSD, and 5-MeO-DMT) on mental health, wellbeing, and behavior, including clinical trials, naturalistic surveys, and reviews of research practices. His work also examines substance use and addiction more broadly, and pays particular attention to how psychedelic experiences affect underrepresented groups such as transgender and gender-expansive people. Prospective students would be exposed to a mix of clinical trial research, survey-based studies, and critical/methodological reviews within the psychedelic and substance-use research field.
Publication output has grown over the past decade, rising from about 9-13 papers per year in 2017-2020 to 14-19 papers per year in 2022-2025, indicating a generally increasing pace of research activity.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- 5-MeO-DMT Use in Humans: A Scoping Review of Peer-Reviewed Research
2026
- Transgender and gender-expansive psychedelic users’ concerns about colonization, racism, and medicalization in western psychedelic science
Psychedelics · 2026
- An international Delphi consensus for reporting of setting in psychedelic clinical trials
Nature Medicine · 2025
- Preliminary safety and effectiveness of psilocybin-assisted therapy in adults with fibromyalgia: an open-label pilot clinical trial
Frontiers in Pain Research · 2025
- A Field-Wide Review and Analysis of Study Materials Used in Psilocybin Trials: Assessment of Two Decades of Research
Psychedelic Medicine · 2025
- Exploring Self-Reported Effects of Naturalistic Psychedelic Use Among Gender and Sexual Minorities: A Quantitative Survey Study
Journal of Psychoactive Drugs · 2025
- Naturalistic psychedelic experiences and gender-based self-acceptance in transgender and gender-expansive people
International Journal of Transgender Health · 2025
- Effect of psilocybin therapy on suicidal ideation, attempts, and deaths in people with psychiatric diagnoses: a systematic review and meta-analysis
Therapeutic Advances in Psychopharmacology · 2025
- Sex Differences in Religious Beliefs Before and After an Entity Encounter During an Ayahuasca Experience
Journal of Psychoactive Drugs · 2025
- Exploring passion for opioid use with a treatment-seeking sample: results from a canonical correlation analysis
Addiction Research & Theory · 2025
- A new season, a new Psychedelics journal
Psychedelics · 2025
- Multivariate associations between passion, coping motives, and substance use outcomes in college students engaging in simultaneous alcohol and marijuana use
Journal of Social Work Practice in the Addictions · 2025
- Reactivations Associated with the Use of 5-MeO-DMT Among Spanish-Speaking Individuals: Prevalence, Predictors, and Emotional Valence
Journal of Psychoactive Drugs · 2025
- Qualitative insights into psilocybin and LSD experiences: Enhanced connection and emotion processing reported by Spanish-speaking survey respondents
Psychedelics · 2025
- A critical literature review of research on attachment and psychedelics: Synergies and research implications
Psychedelics · 2025
- Journal of Psychoactive Drugs×14
- Journal of Psychedelic Studies×12
- PsycTESTS Dataset×9
- Drug and Alcohol Dependence×8
- Journal of Psychopharmacology×6
- Yitong Xin
Psychology · The Ohio State University
- Rafael Lancelotta
Psychology · The Ohio State University
- Nathan D. Sepeda
Psychology · The Ohio State University
- Stacey B. Armstrong
Psychology · The Ohio State University
- Mark Pawson
Medicine · Purdue University West Lafayette
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile